Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3,Condition 4 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000006,left ventricular diastolic blood pressure,,,,5.479,mmHg,0.0734,0.2321,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),49190,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000006,left ventricular diastolic blood pressure,,,,42.617,mmHg,4.4783,14.1615,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46430,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000006,left ventricular diastolic blood pressure,,,,52.41,mmHg,4.5746,14.4662,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47714,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,11,,CMO:0000006,left ventricular diastolic blood pressure,,,,5.8936,mmHg,0.1065,0.3534,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47210,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,11,,CMO:0000198,arterial blood flow rate,,,,10.8618,ml/min/g,1.0033,3.3274,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46666,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,5.661,ml/min/g,0.4679,1.4796,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44731,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,8.446,ml/min/g,0.7247,2.2917,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46883,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,5.454,ml/min/g,0.4231,1.3379,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46214,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000751,percent change in left ventricular developed pressure,post-ischemic value/pre-ischemic value x 100%,,,42.5191,%,6.5653,20.7612,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48540,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,9,,CMO:0000751,percent change in left ventricular developed pressure,post-ischemic value/pre-ischemic value x 100%,,,56.5407,%,7.3717,22.1152,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46332,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000742,percent change in heart rate,post-ischemic value/pre-ischemic value x 100%,,,80.7813,%,6.6691,21.0895,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48308,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,9,,CMO:0000742,percent change in heart rate,post-ischemic value/pre-ischemic value x 100%,,,85.6697,%,4.7258,14.1773,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48419,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000007,left ventricular systolic blood pressure,,,,80.035,mmHg,7.7955,24.6517,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),49901,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000007,left ventricular systolic blood pressure,,,,82.529,mmHg,5.214,16.4882,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),45517,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,11,,CMO:0000007,left ventricular systolic blood pressure,,,,94.7691,mmHg,5.7749,19.1531,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),45742,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,9,,CMO:0000007,left ventricular systolic blood pressure,,,,98.6389,mmHg,3.8769,11.6307,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44828,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,heart left ventricle integrity trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000695,heart left ventricle infarction weight to total heart left ventricle weight ratio,,,,11.25,%,2.3677,7.4875,MMO:0000157,digital scale post excision weight measurement,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours),49409,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 3 hours), 461,PhysGen Cardiac data,heart left ventricle integrity trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,11,,CMO:0000695,heart left ventricle infarction weight to total heart left ventricle weight ratio,,,,9.5255,%,2.4663,8.1798,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours),49711,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 3 hours) 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,11,,CMO:0000664,time to peak heart contraction,,,,1262.0909,s,28.2146,93.5772,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),50240,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours), 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000664,time to peak heart contraction,,,,1211.3,s,34.1461,107.9795,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),46561,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),, 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,11,,CMO:0000663,time to onset of heart contraction,,,,989.5455,s,38.5591,127.8862,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),49312,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours), 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000663,time to onset of heart contraction,,,,950.9,s,36.1477,114.309,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),50132,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000754,percent change in left ventricular systolic blood pressure,post-ischemic value/pre-ischemic value x 100%,,,84.5748,%,7.994,25.2792,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48769,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,9,,CMO:0000754,percent change in left ventricular systolic blood pressure,post-ischemic value/pre-ischemic value x 100%,,,118.9936,%,6.7731,20.3194,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44931,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,11,,CMO:0000665,heart contraction pressure,,,,21.9091,mmHg,2.0647,6.8477,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),50010,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours), 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000665,heart contraction pressure,,,,33.5,mmHg,2.4278,7.6775,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),48046,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,9,,CMO:0000002,heart rate,,,,198.2067,beats/min,8.7188,26.1564,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48958,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,11,,CMO:0000002,heart rate,,,,245.5245,beats/min,5.9142,19.6151,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47595,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,9,,CMO:0000002,heart rate,,,,234.1989,beats/min,10.6242,31.8726,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),48210,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000002,heart rate,,,,202.786,beats/min,16.9837,53.7071,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),45161,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,11,,CMO:0000018,left ventricular developed pressure,,,,88.8755,mmHg,5.7622,19.1112,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),48637,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000018,left ventricular developed pressure,,,,77.05,mmHg,5.1834,16.3912,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46763,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,9,,CMO:0000018,left ventricular developed pressure,,,,43.0167,mmHg,4.3821,13.1462,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47924,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000018,left ventricular developed pressure,,,,37.418,mmHg,5.2514,16.6065,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),45283,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000749,percent change in arterial blood flow rate,post-ischemic value/pre-ischemic value x 100%,,,66.5252,%,5.3186,16.8189,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46079,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000749,percent change in arterial blood flow rate,post-ischemic value/pre-ischemic value x 100%,,,51.1924,%,3.429,10.8436,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47090,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,11,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,0.4833,IU/g,0.1329,0.4409,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47479,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),, 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,19.683,IU/g,2.8535,9.0237,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours),48890,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 1.5 hours), 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,17.8993,IU/g,2.2007,6.9591,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours),45992,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 1.5 hours) 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000339,FHH-Chr YBN/Mcwi,male,63 days to 49 days,9,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,0.6063,IU/g,0.1145,0.3434,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47343,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,